We are live on
!
Find out more
TGI
TRV GP II Portfolio holdings
AUM
$1.34M
1-Year Est. Return
67.55%
This Fund
S&P 500
This Quarter
Est. Return
-24.17%
1 Year Est. Return
-67.55%
3 Year Est. Return
-20.84%
5 Year Est. Return
-49.87%
10 Year Est. Return
–
AUM
$62M
AUM Growth
-$91.4M
(-60%)
Cap. Flow
-$70.4M
Cap. Flow
% of AUM
-113.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
IVAV
VM
CL
GAM
MC
NC
HCIG
NP
TRV GP II's Q2 2019 Portfolio in Review
As of Q2 2019, TRV GP II held 3 positions worth $62M, down 60% from $153M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TRV GP II withdrew a net $70.4M in Q2 2019, closing 1 position. Its most notable exit was Blueprint Medicines, an estimated $70.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- TRV GP II fully exited Blueprint Medicines in Q2 2019, selling an estimated $70.4M.
- TRV GP II's ten largest holdings make up 100% of its $62M portfolio in Q2 2019.
- TRV GP II opened 0 new positions and closed 1 in Q2 2019.
- TRV GP II's portfolio value fell 60% quarter-over-quarter to $62M.
Based on TRV GP II's 13F filing for Q2 2019, filed 6 Aug 2019.